Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBMNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumorNot yet recruitingNot applicable2026-10-09NCT07867886

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Boston Scientific Corporation148
IQVIA RDS Inc.6

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Hospices Civils de Lyon - Hopital Louis PradelBronFrance2
Hôpital de La TimoneMarseilleFrance16
University Medical Center UtrechtUtrechtNetherlands10
Universitätsklinikum TübingenTübingenGermany1
Vall d'Hebron Institute of OncologyBarcelonaSpain9